Back to Journals » Vascular Health and Risk Management » Volume 12


Reversing anticoagulant effects of novel oral anticoagulants: role of ciraparantag, andexanet alfa, and idarucizumab
Total article views | Abstract views | HTML views | PDF downloads | Totals | |
---|---|---|---|---|---|
36,798 | Dovepress* | 7,560 | 3,045+ | 2,835 | 10,605 |
PubMed Central* | 0 | 26,193 | 5,029 | 26,193 | |
Totals | 7,560 | 29,238 | 7,864 | 36,798 | |
*Since 17 February 2016 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
32 | 0 | 0 | 0 | 15 | 17 |
View citations on PubMed Central and Google Scholar